Journal of International Oncology››2015,Vol. 42››Issue (1): 40-42.doi:10.3760/cma.j.issn.1673-422X.2015.01.010
Previous ArticlesNext Articles
Ma Wei, Lu Ying, Mao Jun, Zhao Wenyue, Li Lianhong
Received:
2014-06-19Revised:
2014-07-16Online:
2015-01-08Published:
2015-01-07Contact:
Li Lianhong E-mail:lilianhong917@126.comMa Wei, Lu Ying, Mao Jun, Zhao Wenyue, Li Lianhong. Functional mechanism of SIRT1 gene in tumor[J]. Journal of International Oncology, 2015, 42(1): 40-42.
[1] Liu T, Liu PY, Marshall GM. The critical role of the class Ⅲ histone deacetylase SIRT1 in cancer[J]. Cancer Res, 2009, 69(5): 1702-1705. [2] Zhu X, Liu Q, Wang M, et al. Activation of Sirt1 by resveratrol inhibits TNFα induced inflammation in fibroblasts[J]. PLoS One, 2011, 6(11): e27081. [3] Sestito R, Madonna S, Scarponi C, et al. STAT3dependetnt effects of IL22 in human keratinocytes are counterregulated by sirtuin 1 through a diect inhibiton of STAT3 acetylation[J]. FASEB J, 2010, 25(3): 916-927. [4] Semenza G. HIF1: upstream and downstream of cancer metabolism[J]. Curr Opin Genet Dev, 2010, 20(1): 51-56. [5] Leiser SF, Kaeberlein M. A role for SIRT1 in the hypoxic response[J]. Mol Cell, 2010, 38(6): 779-780. [6] Yuan J, MinterDykhouse K, Lou Z. A cMycSIRT1 feedback loop regulates cell growth and transformation[J]. J Cell Biol, 2009, 185(2): 203-211. [7] Wang RH, Zheng Y, Kim HS, et al. Interplay among BRCA1, SIRT1, and Survivin during BRCA1associated tumorigenesis[J]. Mol Cell, 2008, 32(1): 11-20. [8] Suzuki M, Bartlett JD. Sirtuin1 and autophagy protect cells from fluorideinduced cell stress[J]. Biochim Biophys Acta, 2014, 1842(2): 245-255. [9] Firestein R, Blander G, Michan S, et al. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth[J]. PLoS One, 2008, 3(4): e2020. [10] Yi J, Luo J. SIRT1 and p53, effect on cancer, senescence and beyond[J]. Biochim Biophys Acta, 2010, 1804(8): 1684-1689. [11] Yamakuchi M. MicroRNA regulation of SIRT1[J]. Front Physiol, 2012, 3: 68. [12] Dehennaut V, Loison I, Pinte S, et al. Molecular dissection of the interaction between HIC1 and SIRT1[J]. Biochem Biophys Res Commun, 2012, 421(2): 384-388. [13] Chen HC, Jeng YM, Yuan RH, et al. SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis[J]. Ann Surg Oncol, 2012, 19(6): 2011-2019. [14] Qu Y, Zhang J, Wu S, et al. SIRT1 promotes proliferation and inhibits apoptosis of human malignant glioma cell lines[J]. Neurosci Lett, 2012, 525(2): 168-172. [15] Eades G, Yao Y, Yang M, et al. miR200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)like transformation in mammary epithelial cells[J]. J Biol Chem, 2011, 286(29): 25992-26002. [16] Byles V, Zhu L, Lovaas JD, et al. SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis[J]. Oncogene, 2012, 31(43): 4619-4629. [17] Holloway KR, Calhoun TN, Saxena M, et al. SIRT1 regulates Dishevelled proteins and promotes transient and constitutive Wnt signaling[J]. Proc Natl Acad Sci USA, 2010, 107(20): 9216-9221. [18] Oh WK, Cho KB, Hien TT, et al. Amurensin G, a potent natural SIRT1 inhibitor, rescues doxorubicin responsiveness via downregulation of multidrug resistance 1[J]. Mol Pharmacol, 2010, 78(5): 855-864. [19] Chang CJ, Hsu CC, Yung MC, et al. Enhanced radiosensitivity and radiationinduced apoptosis in glioma CD133positive cells by knockdown of SirT1 expression[J]. Biochem Biophys Res Commun, 2009, 380(2): 236242. [20] Li L, Wang L, Li L, et al. Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib[J]. Cancer Cell, 2012, 21(2): 266-281. [21] Nalls D, Tang SN, Rodova M, et al. Targeting epigenetic regulation of miR34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells[J]. PLoS One, 2011, 6(8): e24099. |
[1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[4] | Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p, H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349. |
[5] | Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353. |
[6] | Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358. |
[7] | Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363. |
[8] | Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[9] | Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[10] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[11] | Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273. |
[12] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[13] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285. |
[14] | Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291. |
[15] | Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||